LUXTURNA has significant market potential due to the high unmet need for effective treatments in rare genetic conditions. With its FDA approval for specific mutations in the RPE65 gene, it offers ...
4d
DelveInsight's "LUXTURNA Market Size, Forecast, and Market Insight Report" highlights the details around LUXTURNA, a one-time ...
Bottles of over-the-counter Benadryl sold on Amazon are being recalled nationwide because they pose a safety risk to children ...
This approval augments Biocon Pharma's complex injectables portfolio and reinforces its footprint in the US pharma market.
Norepinephrine bitartrate injection is indicated to raise blood pressure in adult patients with acute hypotension.
Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, today announced that the Centers for Medicare ...
US Food and Drug Administration (US FDA) for its ANDA Norepinephrine Bitartrate Injection USP, 4 mg/4 mL (1 mg/mL) ...
Bengaluru: Biocon has announced that Biocon Pharma Limited, a wholly owned subsidiary of the Company, has received approval ...
The approval covers the norepinephrine bitartrate injection 4 mg/4 mL (1 mg/mL) single-dose vial, which can now be ...
Norepinephrine bitartrate injection is a critical medication used to raise blood pressure in adult patients suffering from ...
Biocon Pharma Limited receives FDA approval for Norepinephrine Bitartrate Injection USP, expanding its complex drug portfolio ...
From discovery sets to flexible returns, niche names to premium designer perfumes - here's how to make sure you love your ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback